Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa

European Journal of Medicinal Chemistry

Volumn 46, Issue 7, 2011, Pages 3118-3123

  MacAbeo, Allan Patrick G ^a,b   Vidar, Warren S ^a   Chen, Xinyu ^b   Decker, Michael ^b   Heilmann, Jörg ^b   Wan, Baojie ^c   Franzblau, Scott G ^c   Galvez, Elano V ^a   Aguinaldo, Ma Alicia M ^a   Cordell, Geoffrey A ^d  

^a UNIVERSITY OF SANTO TOMAS   (Philippines)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Natural Products Inc   (United States)

Author keywords

Antitubercular; Aspidosperma Aspidosperma bisindole alkaloids; Cholinesterase activity; Voacanga globosa

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DEOXYVOBTUSINE; DEOXYVOBTUSINE LACTONE; GALANTAMINE; GLOBOSPIRAMINE; INDOLE ALKALOID; ISONIAZID; LUPEOL; MOXIFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; VOBTUSINE LACTONE; ALKALOID; OXAZINE DERIVATIVE; PENTACYCLIC TRITERPENE; PLANT EXTRACT; RESAZURIN; SPIRO COMPOUND; XANTHENE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHOLINESTERASE INHIBITION; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; IC 50; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PLANT LEAF; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; STEREOCHEMISTRY; VOACANGA; VOACANGA GLOBOSA; ANIMAL; CHEMISTRY; DRUG EFFECTS; ELECTROPHORUS; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HORSE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINESTERASE; ALKALOIDS; ANIMALS; ANTITUBERCULAR AGENTS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ELECTROPHORUS; HORSES; INDOLE ALKALOIDS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXAZINES; PENTACYCLIC TRITERPENES; PLANT EXTRACTS; PLANT LEAVES; SPIRO COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; VOACANGA; XANTHENES;

EID: 79957515461     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.04.025     Document Type: Article

References (30)

1. World Health Organization Tuberculosis facts 2010/2011 http://www.who.int/tb
2. L. Ballell, R.A. Field, K. Duncan, and R.J. Young New small-molecule synthetic antimycobacterials Antimicrob. Agents Chemother. 49 2005 2153 2163 (Pubitemid 40734441)
3. J.P. Cegielski, D.P. Chin, M.A. Espinal, T.R. Frieden, R. Rodriguez-Cruz, E.A. Talbot, D.E. Weil, R. Zaleskis, and M.C. Raviglione Prospects for the 21st century Infect. Dis. Clin. North Am. 161 2002
4. D. Maher, and M. Raviglione Global epidemiology of tuberculosis Clin. Chest Med. 26 2005 167 182
5. A.V. Terry, and J.J. Buccafusco The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development J. Pharmacol. Exp. Ther. 306 2003 821 827 (Pubitemid 37025286)
6. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766 (Pubitemid 32267077)
7. A. Shvaloff, E. Neuman, and D. Guez Lines of therapeutics research in Alzheimer's disease Psychopharmacol. Bull. 32 1996 343 352 (Pubitemid 26365646)
8. G.K. Wilcock Current approaches to the treatment of Alzheimer's disease Neurogeneration 5 1996 505 509 (Pubitemid 27077917)
9. R.T. Bartus, L.D. Dean, B. Beer, and A. Lippa The cholinergic hypothesis of geriatric memory dysfunction: a critical review Science 217 1982 408 417 (Pubitemid 12048290)
10. R.E. Becker, P. Moriearty, L. Unni, and S. Vicari Alzheimer's Disease: From Molecular Biology to Therapy 1997 Birkhäuser Boston
11. J.N. Johnson, A. Roland, and N. Upton Drug discovery today Ther. Strateg. 1 2004 13 19
12. K. Hostettmann, A. Borloz, A. Urbain, and A. Marston Natural product inhibitors of acetylcholinesterase Curr. Org. Chem. 10 2006 825 847
13. P.J. Houghton, Y. Ren, and M.J. Howes Acetylcholinesterase inhibitors from plants and fungi Nat. Prod. Rep. 23 2006 181 199
14. A.P.G. Macabeo, G.J.D. Alejandro, A.V. Hallare, W.S. Vidar, and O.B. Villaflores Phytochemical survey and pharmacological activities of the indole alkaloids in the genus Voacanga Thouars (Apocynaceae) - an update Pharmacog. Rev. 3 2009 132 142
15. A.P.G. Macabeo, K. Krohn, D. Gehle, G.A. Cordell, S.G. Franzblau, and A.M. Aguinaldo Indole alkaloids from the leaves of Philippine Alstonia scholaris Phytochemistry 66 2005 1158 1162 (Pubitemid 40728311)
16. A.P.G. Macabeo, L.T. Byrne, S.G. Franzblau, and A.M. Aguinaldo 19,20E-Akuammidine from the bioactive alkaloid fraction of Alstonia scholaris leaves ACGC Chem. Res. Comm. 20 2006 11 13
17. 37Rv in vitro Int. J. Antimicrob. Agents 27 2007 744 746 (Pubitemid 46722679)
18. 37Rv Phil. Agri. Sci. 91 2008 348 351
19. Y. Rolland, N. Kunesch, J. Poisson, E.W. Hagaman, F.M. Schell, and E. Wenkert Carbon-13 nuclear magnetic resonance spectroscopy of naturally occurring substances 43. Carbon-13 nuclear magnetic resonance analysis of bis-indoline alkaloids of two Voacanga species J. Org. Chem. 41 1976 3270 3275
20. K. Zaima, T. Hirata, T. Hosoya, Y. Hirasawa, K. Koyama, A. Rahman, I. Kusumawati, N.C. Zaini, M. Shiro, and H. Morita Biscarpamontamines A and B, an Aspidosperma-Iboga alkaloid and Aspidosperma-Aspidosperma bisindole alkaloid from Tabernaemontana sphaerocarpa J. Nat. Prod. 72 2009 1686 1690
21. 13C Nuclear magnetic resonance of lupane-type triterpenes, lupeol, betulin and betulinic acid Chem. Pharm. Bull. 28 1980 1006 1008 (Pubitemid 11248173)
22. L.A. Collins, and S.G. Franzblau Microplate Alamar blue assay versus BACTEC 460 System for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium Antimicrob. Agents Chemother. 41 1997 1004 1009 (Pubitemid 27194176)
23. N. Bibi, S. Tanoli, K. Ahmad, S. Farheen, N. Afza, S. Siddiqi, Y. Zhang, S. Kazmi, and A. Malik In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum Bioorg. Med. Chem. Lett. 20 2010 4173 4176
24. S.H. Cho, S. Warit, B. Wan, C.H. Hwang, G.F. Pauli, and S.G. Franzblau Low-oxygen recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis Antimicrob. Agents Chemother. 51 2007 1380 1385 (Pubitemid 46586820)
25. L.B. Adams, L. Sinha, S.G. Franzblau, J.L. Krahenbuhl, and R.T. Mehta Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine Antimicrob. Agents Chemother. 43 1999 1638 1643 (Pubitemid 29331240)
26. B.R. Copp, and A.N. Pierce Natural product growth inhibitors of Mycobacterium tuberculosis Nat. Prod. Rep. 24 2007 278 297 (Pubitemid 46496562)
27. M. Decker Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine Eur. J. Med. Chem. 40 2005 305 313 (Pubitemid 40255773)
28. M. Decker, F. Krauth, and J. Lehmann Novel Tricyclic Quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase Bioorg. Med. Chem. 14 2006 1966 1977 (Pubitemid 43199528)
29. Z.-J. Zhan, Q. Yu, Z.-L. Wang, and W.G. Shan Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities Bioorg. Med. Chem. Lett. 20 2010 6185 6187
30. G.A. Cordell, M.L. Quinn-Beattie, and N.R. Farnsworth The potential of alkaloids in drug discovery Phytother. Res. 15 2001 183 205 (Pubitemid 32463303)